发明名称 New linear cyclic ureas
摘要 Compound of formula (I): wherein: V represents a single bond or an alkylene chain, M represents a single bond or an alkylene chain, A and E each represents nitrogen or CH, but at least one of the two groups A or E represents nitrogen, W represents a group of formula (i), (ii) or (iii): wherein: X represents carbonyl, sulphonyl or sulphoxide, G1, G2 and G3 are as defined in the description, T represents a fused phenyl group or a fused pyridyl group, R1 represents hydrogen, linear or branched (C1-C6)alkyl, aryl or aryl-(C1-C6)alkyl in which the alkyl moiety is linear or branched, R2a and R2b, which are the same or different, are as defined in the description, R3 represents aryl or heteroaryl-A as defined in the description, each of which groups may optionally be substituted, Y represents aryloxy, heteroaryloxy or heteroaryl-B as defined in the description, each of which groups may optionally be substituted, its isomers, its hydrates, its solvates and addition salts thereof with a pharmaceutically acceptable acid. Medicinal products containing the same which are useful in the treatment of diseases or pathological conditions in which endothelial dysfunction is known.
申请公布号 US2003191132(A1) 申请公布日期 2003.10.09
申请号 US20020292358 申请日期 2002.11.12
申请人 PEGLION JEAN-LOUIS;POITEVIN CHRISTOPHE;VILAINE JEAN-PAUL;VILLENEUVE NICOLE;BOURGUIGNON MARIE-PIERRE;THOLLON CATHERINE 发明人 PEGLION JEAN-LOUIS;POITEVIN CHRISTOPHE;VILAINE JEAN-PAUL;VILLENEUVE NICOLE;BOURGUIGNON MARIE-PIERRE;THOLLON CATHERINE
分类号 C07D417/14;A61K31/437;A61K31/4427;A61K31/443;A61K31/4439;A61K31/454;A61K31/4545;A61K31/4709;A61K31/4725;A61K31/496;A61K31/497;A61K31/506;A61K31/513;A61K31/551;A61P3/06;A61P3/10;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P43/00;C07D209/08;C07D211/26;C07D211/58;C07D401/06;C07D401/12;C07D403/06;C07D405/06;C07D405/12;C07D405/14;C07D413/12;C07D417/06;C07D471/04;C07D491/04;(IPC1-7):A61K31/506;C0743/14 主分类号 C07D417/14
代理机构 代理人
主权项
地址